SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-23-002843
Filing Date
2023-08-02
Accepted
2023-08-02 18:26:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4071
  Complete submission text file 0001959173-23-002843.txt   5465
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Subject) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37708 | Film No.: 231137430
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FOREST LABORATORIES, INC. 909 THIRD AVENUE NEW YORK NY 10022
Business Address
Meury William (Reporting) CIK: 0001536778 (see all company filings)

Type: 144